FDA Inspection
Hainan Shuangcheng Pharmaceuticals Co LtdHainan Shuangcheng Pharmaceuticals Co Ltd – FDA Inspection, May 26, 2017
Record Details
This FDA Inspection record concerns Hainan Shuangcheng Pharmaceuticals Co Ltd, with an inspection on May 26, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Katherine Szestypalow (Issuing Officer)
- Santos E. Camara (Issuing Officer)
View Company Profile
ID · 67c916f6-e637-4c05-8fc1-7abb0045a243
Inspection Facts
- Inspection number
- 1019204
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Hainan Shuangcheng Pharmaceuticals Co Ltd
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 28, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 22, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hainan Shuangcheng Pharmaceuticals Co Ltd
- FDA Inspection 1229377 - 2024-01-26
- FDA Inspection 1087910 - 2019-04-24
- FDA Inspection 957459 - 2016-01-28
- FDA Inspection 850842 - 2013-08-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.